ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,089Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 717

$874K Total Retail Price of All Prescriptions

Rank: 14 out of 717

344 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 344 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

6% of this provider’s 344 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 12,383 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 33%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $88 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
WARFARIN SODIUM 536 449 1 7
AMLODIPINE BESYLATE 411 392 2 2
FUROSEMIDE 405 400 3 5
LEVOTHYROXINE SODIUM 373 347 4 23
DONEPEZIL HCL 364 345 5 57
GABAPENTIN 360 325 6 62
SIMVASTATIN 337 310 7 3
METOPROLOL TARTRATE 320 286 8 8
CLONIDINE HCL 256 242 9 48
OMEPRAZOLE 235 210 10 28
MIRTAZAPINE 210 198 11 117
SPIRONOLACTONE 193 184 12 31
PANTOPRAZOLE SODIUM 192 178 13 49
PREDNISONE 185 185 14 90
NAMENDA 175 175 15 78
LISINOPRIL 168 163 16 9
FAMOTIDINE 163 120 17 51
SERTRALINE HCL 163 153 17 81
CITALOPRAM HBR 157 137 19 118
CARVEDILOL 154 142 20 6
METFORMIN HCL 147 105 21 30
AZITHROMYCIN 137 122 22 55
POTASSIUM CHLORIDE 136 131 23 27
METOPROLOL SUCCINATE 132 127 24 1
DIGOXIN 130 130 25 14
TAMSULOSIN HCL 130 116 25 70
ZOLPIDEM TARTRATE 128 95 27 35
CYMBALTA 128 87 27 131
OXYCODONE-ACETAMINOPHEN 124 85 S2 29 88
CLOPIDOGREL 113 97 30 10
KLOR-CON M20 104 101 31 71
ATENOLOL 101 101 32 18
CRESTOR 97 87 33 11
PAROXETINE HCL 97 97 33 160
LIDODERM 94 89 35 105
DIVALPROEX SODIUM 92 79 36 103
ESCITALOPRAM OXALATE 85 74 37 106
ATORVASTATIN CALCIUM 84 78 38 4
DOXYCYCLINE HYCLATE 84 77 38 205
ALENDRONATE SODIUM 84 84 38 69
CARBIDOPA-LEVODOPA 83 70 41 165
OXYCODONE HCL 82 0 S2 42 167
PLAVIX 81 69 43 12
NEXIUM 81 81 43 37
FENTANYL 81 76 S2 43 154
QUETIAPINE FUMARATE 80 78 46 125
LOSARTAN POTASSIUM 79 79 47 16
DIOVAN 78 78 48 13
TRAZODONE HCL 78 58 48 172
LANTUS 78 52 48 141
ABILIFY 76 65 51 174
FLUTICASONE PROPIONATE 73 65 52 110
SODIUM CHLORIDE 73 60 52 153
RISPERIDONE 71 68 54 115
HYDROCODONE-ACETAMINOPHEN 71 67 S3 54 91
HYDROMORPHONE HCL 70 13 S2 56 217
SPIRONOLACTONE-HCTZ 67 67 57 93
MELOXICAM 66 62 58 82
METHADONE HCL 62 0 S2 59 230
METOLAZONE 62 60 59 119
FLUOCINONIDE 59 58 61 234
OXYCONTIN 59 34 S2 61 234
KADIAN 58 38 S2 63 239
RAMIPRIL 57 57 64 15
PRAVASTATIN SODIUM 57 57 64 21
LEVETIRACETAM 56 45 66 147
SPIRIVA 55 49 67 99
NOVOLOG 54 46 68 164
BUMETANIDE 53 47 69 101
OXYBUTYNIN CHLORIDE ER 53 47 69 254
NYSTATIN-TRIAMCINOLONE 53 47 69 254
GLIMEPIRIDE 51 38 72 59
GLYBURIDE 50 31 R 73 139
CIPROFLOXACIN HCL 50 48 73 112
ENALAPRIL MALEATE 50 41 73 24
LANTUS SOLOSTAR 50 46 73 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.